Fentanyl Citrate

CHEMBL688 Phase 4 अनुमोदित Small molecule
Half-Life
Bioavailability
Protein Binding
Molecular Weight
528.6 g/mol
LogP
Phase
4

This citrate salt form of fentanyl is a highly potent opioid analgesic used to manage severe pain, often administered in hospital settings or for breakthrough cancer pain. It binds strongly to opioid receptors in the central nervous system and requires careful dosing due to its high risk of respiratory depression.

आणविक भार

528.6000 g/mol

TPSA

156.00 Ų

चिकित्सीय क्षेत्र

अग्नाशय कैंसर अनिद्रा अल्ज़ाइमर रोग अस्थमा इंफ्लेमेटरी बाउल डिज़ीज़ उच्च रक्तचाप एट्रियल फ़िब्रिलेशन ओवेरियन कैंसर कोलोरेक्टल कैंसर क्रॉनिक ऑब्सट्रक्टिव पल्मोनरी डिज़ीज़ (COPD) क्रॉनिक किडनी डिज़ीज़ जनरलाइज़्ड एंग्ज़ाइटी डिसऑर्डर टाइप 2 मधुमेह थायरॉइड कैंसर दर्द प्रबंधन दीर्घकालिक दर्द नॉन-अल्कोहलिक फैटी लिवर डिज़ीज़ नॉन-स्मॉल सेल लंग कैंसर प्रसूति एवं स्त्री रोग प्रोस्टेट कैंसर बाइपोलर डिसऑर्डर बिनाइन प्रोस्टेटिक हाइपरप्लासिया माइग्रेन मिर्गी (एपिलेप्सी) मूत्राशय कैंसर मेलानोमा मोटापा रुमेटॉइड आर्थराइटिस लिम्फोमा ल्यूकेमिया सिज़ोफ्रेनिया स्ट्रोक स्तन कैंसर हृदय विफलता हृदय-संवहनी रोग

क्रिया का तंत्र

Binds to mu (μ), kappa (κ), and/or delta (δ) opioid receptors in the central and peripheral nervous system, mimicking endogenous endorphins. Activation of these G-protein-coupled receptors inhibits pain signal transmission and modulates the emotional response to pain.

Pharmacokinetics (PK)

Pharmacodynamics (PD)

तंत्र

Binds to mu (μ), kappa (κ), and/or delta (δ) opioid receptors in the central and peripheral nervous system, mimicking endogenous endorphins. Activation of these G-protein-coupled receptors inhibits pain signal transmission …

2D संरचना

SVG PNG

Cite this structure


                        

Embed this structure


                        

SMILES

CCC(=O)N(c1ccccc1)C1CCN(CCc2ccccc2)CC1.O=C(O)CC(O)(CC(=O)O)C(=O)O

InChI

InChI=1S/C22H28N2O.C6H8O7/c1-2-22(25)24(20-11-7-4-8-12-20)21-14-17-23(18-15-21)16-13-19-9-5-3-6-10-19;7-3(8)1-6(13,5(11)12)2-4(9)10/h3-12,21H,2,13-18H2,1H3;13H,1-2H2,(H,7,8)(H,9,10)(H,11,12)

Molecular Formula

C28H36N2O8

HBD / HBA

4 / 9

घूर्णनीय बंधन

11

भारी परमाणु

38

No targets recorded

Target interaction data is not yet available for this drug.

No interactions recorded

Drug interaction data is not yet available for this compound.

No side effects recorded

Side effect data is not yet available for this drug.

अक्सर पूछे जाने वाले प्रश्न

This citrate salt form of fentanyl is a highly potent opioid analgesic used to manage severe pain, often administered in hospital settings or for breakthrough cancer pain. It binds strongly to opioid receptors in the central nervous system and requires careful dosing due to its high risk of respiratory depression.

Binds to mu (μ), kappa (κ), and/or delta (δ) opioid receptors in the central and peripheral nervous system, mimicking endogenous endorphins. Activation of these G-protein-coupled receptors inhibits pain signal transmission and modulates the emotional response to pain.

Yes, Fentanyl Citrate is an approved drug. It has reached clinical phase 4. It is classified as a Small molecule.

{# References & Data Sources section for drug detail pages. Renders standard pharmacological database links plus the drug's data_sources field. #}

References & Data Sources

  • ChEMBL — European Bioinformatics Institute (EBI). CHEMBL688. Open-access bioactivity database.
  • PubChem — National Center for Biotechnology Information (NCBI). CID 13810. Chemical information database.

Data aggregated from publicly available pharmacological databases. Last updated 2026-03-04.

चिकित्सा अस्वीकरण

This content is for educational and informational purposes only. It is not a substitute for professional medical advice, diagnosis, or treatment. Always consult a qualified healthcare provider before making medication decisions.

Data sources: ChEMBL, PubChem, DailyMed.